Focused radiation to main prostate tumor using MRI guidance
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a stronger, more focused radiation dose to the main tumor inside the prostate using MRI guidance. It aims to improve control of intermediate-risk prostate cancer while possibly reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have intermediate-risk prostate cancer (PSA between 10 and 20, or Gleason score of 7, or the tumor has spread to more than half of one side or both sides of the prostate).
- You must be over 18 years old and in generally good health (able to perform daily activities without help).
- Your prostate must be smaller than 90 cc (about the size of a small lemon).
- You must have at least one visible tumor on MRI that is at least 0.5 cm and no more than two other suspicious spots.
- You must not have had prior hormone therapy for prostate cancer, pelvic radiation, or certain other prostate procedures.
- You must be able to safely undergo an MRI (no metal implants, pacemaker, claustrophobia, etc.) and fill out symptom questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single, image-guided radiation treatment can treat intermediate-risk prostate cancer while better protecting the urethra (the urine tube). It may help patients get effective cancer control with potentially fewer urinary side effects, depending on the results.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.